NVO241213P117000
- 6.20
- -2.00-24.39%
Novo-Nordisk A/S Newsroom
Catalent Gains After Report Sale to Novo Holdings Could Close Soon
10 Health Care Stocks Whale Activity In Today's Session
Express News | Eli Lilly and Co will conduct research on whether weight loss drugs can effectively control addictive behavior.
Evotec And Novo Nordisk Launch First Projects For LAB EN2 Accelerator, Focusing On Cardiometabolic Diseases
Eli Lilly and Co (LLY.US) seeks to expand the indications for its weight loss medication and will conduct trials to treat addictive behaviors.
Eli Lilly and Co will test a weight loss drug for treating addiction in 2025.
BofA Restarts Coverage of 11 Large-cap Biopharmas
Novo Nordisk's Wegovy Sales Drop Is Temporary; Forecasts Still on Track -- Market Talk
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Eikonizo Therapeutics Announces Investment by Novo Nordisk; Advancing Lead Candidate EKZ-102 Toward Clinical Development
Novo Nordisk Says Investment Aimed At Expanding Enzymes Output Used For The Production Of Insulin, GLP-1 Medicines
Novo Nordisk To Invest Additional 500M Reais To Expand Factory In Brazil
Novo Nordisk Just Got One Step Closer to Resolving Wegovy Supply Issue -- Barrons.com
PFE or NVO: Which Is the Better Value Stock Right Now?
Phase 2 Data From the Ongoing HIBISCUS Study Shows Promise That Investigational Etavopivat Could Reduce the Incidence of Vaso-occlusive Crises in People With Sickle Cell Disease
Express News | The European Union has unconditionally approved Novo Holdings' acquisition of the pharmaceutical contract manufacturer Catalent.
Novo Holdings' acquisition of the drug manufacturer catalent (CTLT.US) trade has been approved by the EU.
Novo Nordisk's parent company, Novo Holdings, acquired the drug manufacturer Catalent (CTLT.US) and the trade was approved by the European Union, with the transaction involving $16.5 billion. Regulatory institutions stated this week that after finding that the agreement would not raise competition concerns in the European Economic Area, the EU unconditionally approved the trade.
Catalent's Proposed Acquisition by Novo Holdings Wins European Commission Nod
European Equities Traded in the US as American Depositary Tread Water in Friday Trading
US stocks move | Selling Czech factory, novavax (NVAX.US) rises over 12%.
As of the time of writing, the stock has risen over 12%, reported at $9.355.
Novo Nordisk Catalysts Could Drive Over 30% Upside to Shares -- Market Talk